FUNDACION PUBLICA PROGRESO Y SALUD TECHNOLOGY TRANSFER OFFICE OF ANDALUSIAN PUBLIC HEALTH SYSTEM.

Slides:



Advertisements
Similar presentations
Campus BioTic Shared commitment to shared development Teodoro Luque Martínez University of Granada.
Advertisements

Presentation for HL7 RCRIM and Clinical Genomics SIG HL7 Working Group Meeting San Diego, CA 21Jan2004.
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
How might we cure diseases in the future?. Using what we know about genes Pharmacogenetics/ Pharmacogenomics Gene Therapy Regenerative medicine.
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.
Stem Cell Dream: From Reality to Dreams. EuroStemCell is a unique partnership of European scientists, clinicians, ethicists, social scientists and science.
Stem Cells: Roadmap to the clinic Negar Azarpira, MD Associate professor of Pathology 14 April 2010.
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Bioscience/Biomedical Research at Idaho State University Christopher Daniels, Ph.D. Director, ISU Biomedical Research Institute and Professor of Pharmaceutical.
Bioinformatics and the Engineering Library ASEE 2008 Amy Stout.
Personalized Medicine Presentation by: Alex Wiki by: John and Lydia.
Who am I? A Brief Bio PhD with John Schrader at The Biomedical Research Centre (UBC) Undergrad at Simon Fraser University Genetics: 3 summers in a Drosophila.
Definition of Clinical Research in Rehabilitation What is involved? What is studied? Where is it done? Patient oriented research  patient interaction.
HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
1 Karolinska University Hospital. –Presentation Heikki Teriö, FoU-manager Education:Applied Physics and Electronics Linkoping University of Technology.
Development of Bioinformatics and its application on Biotechnology
Stem Cells and Cell Differentiation. Embryonic Stem Cells - Blastocyst Stage 3 parts: –Trophoblast –Blastocoel (“blastoseel”) or blastocyst cavity –Inner.
Introduction Medical biotechnology is the fusion of genetics, cell biology and many other sciences in order to further advances in medicine.
BioSciencs Foro November 8th, New York Joaquin Guinea Chairman of BIOMADRID (
European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York.
Rainer Gruessner Rainer Gruessner Professor Department of Surgery University of Arizona USA Tel: Fax:
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
UWA, COVS and LEI COVS is effectively the academic arm of LEI through which competitive research grants are managed and to which academic appointments.
September 2011 Вивари (в том числе spf-зона) Лаборатория Офисная зона Учебная зона (аудитории) September 2013.
Detecting Genetic Diseases Karyotyping Amniocentisis Chorionic Villus Sampling (CVS) Adult Karyotyping FISH RFLPs SNPs Microarray Analysis.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
Living Lab Salud Andalucía Presentation June 2009 Bidatzi Marin IAVANTE Foundation.
BIOLOGY 12 Biotechnology. What is Biotechnology? biotechnology is technology based on biology biotechnology harnesses cellular and biomolecular processes.
MEDICAL LABORATORY TECHNOLOGY What will I do? Perform tests on human blood, tissue and fluid Be a part of the health care team Help the doctor diagnose.
The Value of Tissue Banks to Drug and Dx Developers Barbara L. Handelin, Ph.D. Conflicts of Interest, Privacy/Confidentiality, and Tissue Repositories:
What is Biotechnology? “a collection of technologies that use living cells and/or biological molecules to solve problems and make useful products”
CO 1: Ability to explain foundations of modern biotechnology.
Biomedical Engineering at the Centre for Preclinical Research and Technology Contemporary medicine is challenged to seek methods for delaying and alleviating.
D4FF55A0-6B6F BF422A9BA9 Present by: Xiao Chen On December 7, 2015.
12-9 and Turn In: Concept Map and Vocabs Warm up# 11-15
An initiative of the International Rare Diseases Research Consortium-IRDiRC Spanish Rare Diseases Registries Research Network - SpainRDR
Research Priorities & Trends for NIH in 2003 Claire T. Driscoll Director Technology Transfer Office National Human Genome Research Institute (NHGRI) Research.
Consumer Advocate Perspective Clinical Trials Registration Sharon F. Terry, JAM Sharon F. Terry, JAM President and CEO, Genetic Alliance, Inc. Founding.
Prof : Heba M Saad Eldien Manager Of Tissue Culture And Molecular Biology center Deputy director Of Genetic and metabolic disorders Lab Professor.
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
Bachelor of Biomedical Science Department of Biological.
STEM CELL RESEARCH. What are stem cells? Cells that can generate more copies of themselves Have specialized function in body.
IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
New research areas in personalised medicines
BIOMEDICAL ENGINEERING
Stem Cells: Scientific Potential and Alternatives
La nuova biologia.blu Anatomia e fisiologia dei viventi S
Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer.
How might we cure diseases in the future?
International Journal of Medical Biotechnology & Genetics
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Companies Researching Cancer Treatments By: Amanda Garcia
Biomedical Therapies Foundation Standard 1: Academic Foundation
Regenerative Medicine
Regenerative Medicine Market Is Expected To Reach $ Million By 2025 | CAGR 33.05% - Progressive Markets - Size, Trend, Share, Opportunity Analysis.
What is Biotechnology? “a collection of technologies that use living cells and/or biological molecules to solve problems and make useful products”
Genetic Engineering, Stem Cells, and Cloning
Novara Italy Expertise in:
Stem Cells and Cellular Differentiation
Objective 1 Biomedical Research
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Retreat Topics iPSC Opportunities in NIAMS Diseases
Integration of Genomic Medicine into Pathology Residency Training
What is Biotechnology? “a collection of technologies that use living cells and/or biological molecules to solve problems and make useful products”
MD Tech Council – Doing Biz w/ NIH
Presentation transcript:

FUNDACION PUBLICA PROGRESO Y SALUD TECHNOLOGY TRANSFER OFFICE OF ANDALUSIAN PUBLIC HEALTH SYSTEM

Andalusia, investing in health, investing in people. WHERE WE ARE… ANDALUSIA 9 Million people km² (8 provinces) 6 airports / Speed train 300 sunny days / year

Andalusia, investing in health, investing in people. THE FOUNDATION

Andalusia, investing in health, investing in people. THE FOUNDATION HOW WE DO IT

Andalusia, investing in health, investing in people. THE FOUNDATION HOW WE DO IT

Andalusia, investing in health, investing in people. ANDALUSIAN PUBLIC HEALTH SYSTEM MAIN RESEARCH ACTIVITIES OncologyDiabetes Neurodegenerative diseases Cardiovascular Diseases Rare DiseasesMental IllnessObesityInfectious Diseases RESEARCH ACTIVITY

Andalusia, investing in health, investing in people. SPECIALIZED RESEARCH CENTRES SPECIALIZED LABORATORIES CLINICAL TRIALS

Andalusia, investing in health, investing in people. SPECIALIZED RESEARCH CENTRES SPECIALIZED LABORATORIES

Andalusia, investing in health, investing in people. RESEARCHEDUCATIONTHERAPY TECH TRANSFER 12 GMP Rooms 12 Clinical Trials on going

Andalusia, investing in health, investing in people. ANDALUSIAN BIOBANK NETWORK & DIRAYA DIRAYA is a pioneering software that collects the clinical data of Andalusian citizens. 8,5 Million People This software in combination with the MGP is an extremely powerful tool for carrying out prospective and retrospective clinical studies or providing applications in the theranostic field.

Andalusia, investing in health, investing in people. ANDALUSIAN PUBLIC HEALTH SYSTEM YOUR PARTNER FOR RESEARCH COLABORATION

Andalusia, investing in health, investing in people. RESEARCH CENTERS CELULLAR THERAPY AND REGENERATIVE MEDICINE Pancreatic Regeneration and Cellular Therapy against Diabetes Mellitus Inmunology and Tolerance Induction Oncology and Molecular Pathology Tissue Engineering and Biomaterials Transplant and Vertebrate regenaration

Andalusia, investing in health, investing in people. RESEARCH CENTERS GENOMIC AND ONCOLOGIC RESEARCH : Human DNA variability Oncologic Genomic Pharmacogenomic

Andalusia, investing in health, investing in people. RESEARCH CENTERS NANOMEDICINE AND BIOTECHNOLOGY : Nanodiagnostic New nanometric systems Development of new tissue engineering technologies

Andalusia, investing in health, investing in people. GMP ROOMS 3 in Seville 4 in Malaga3 in Cordoba 2 in Granada 12 GMP ROOMS in Andalusia

Andalusia, investing in health, investing in people. ESPECIALIZED LABORATORIES Characterization of a huge number of genetic diseases, with the aim to know the genes variations to determinate the genes involved in monogenic diseases. The great majority of these diseases are rare diseases. MGP (MEDICAL GENOME PROYECT)

Andalusia, investing in health, investing in people. SPECIALIZED LABS Cellular Therapy and Regenerative Medicine Research Furthermore, a clinical trial will be done in cellular therapy with IPS cells in tetraplegic patients with spinal cord injuries ( when the preclinic phase makes propoer progress). CELLULAR REPROGRAMMING LABORATORY

Andalusia, investing in health, investing in people. THANK YOU FOR YOUR ATTENTION!